HONLIV HEALTH announced its 2024 performance, with profit attributable to owners of the company at 31.151 million yuan, a year-on-year decrease of 18.7%

Zhitong
2025.03.28 16:20
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, HONLIV HEALTH announced its 2024 performance, with revenue of approximately 769 million yuan, a year-on-year increase of 1.1%. The profit attributable to the company's owners was 31.151 million yuan, a year-on-year decrease of 18.7%. The basic and diluted earnings per share were 0.06 yuan. The announcement stated that the revenue growth was mainly due to the increase in income from treatment and comprehensive medical services as well as pharmaceutical sales

According to the Zhitong Finance APP, HONLIV HEALTH (09906) announced its 2024 performance, with revenue of approximately 769 million yuan, a year-on-year increase of 1.1%. The profit attributable to the company's owners was 31.151 million yuan, a year-on-year decrease of 18.7%. The basic and diluted earnings per share were 0.06 yuan.

The announcement stated that the revenue growth was mainly due to the increase in income from treatment and comprehensive medical services as well as pharmaceutical sales

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer